Thursday, May 17, 2012
Sunscreen ingredient women may want to avoid
A recent study in Environmental Science and Technology has shown that a potent sunscreen ingredient, oxybenzone, may be a cause of endometriosis. This condition occurs when uterine tissue grows in abnormal sites in the abdomen and causes severe pain. In this study of 600 women, those with the highest levels of a form of oxybenzone in their urine had a 65 percent increased risk of endometriosis. Oxybenzone, like bisphenol-A (BPA), is a chemical that mimics estrogen. And endometriosis growth is fed by estrogen.
Thursday, May 10, 2012
Successful, drug-free cardiac prevention
An aggressive and comprehensive cardiac rehabilitation program by clinicians in the west of Ireland resulted in significant reductions in body weight and improved other lifestyle behaviors in a cohort of patients and their partners at high risk for cardiovascular disease events.
The multidisciplinary program includes physicians, nurses, physical-activity specialists, social workers, dieticians, and targeted patients referred by family physicians as high risk for cardiovascular events based on their risk-factor profile. The results of the study, which included changes in diet and physical-activity levels, were presented at EuroPrevent 2012.
"We would hope that policymakers would be influenced by the success of the program and by its inherent simplicity," said the lead physician. "We hope that they would look to this as a useful model of prevention that they could employ in their own setting or perhaps in primary-care centers where there is a multidisciplinary team available."
The 12- to 16-week primary-prevention program including patients and partners or spouses, was designed to alter the lifestyle behaviors of spouses/partners because aberrant behavior, especially in terms of diet and physical-activity patterns, tends to be shared.
Overall, mean body-mass index and waist-circumference measurements were reduced in the high-risk patients and their partners. In addition, there was greater adherence to the Mediterranean diet; a larger proportion of individuals reaching the daily recommended targets of fruit, vegetable, and fish consumption; and a reduction in salt use. There were dramatic improvements in physical-activity levels, with more than 60% of patients and their partners meeting the daily requirement for physical activity, up from 11% of patients and 20% of partners who were exercising before the intervention.
Sustainable and simple, "this is a model of a primary-prevention practice that we would hope would be disseminated throughout Ireland," said the lead physician.
Steve: Sustainable and simple. Words to live by.
The multidisciplinary program includes physicians, nurses, physical-activity specialists, social workers, dieticians, and targeted patients referred by family physicians as high risk for cardiovascular events based on their risk-factor profile. The results of the study, which included changes in diet and physical-activity levels, were presented at EuroPrevent 2012.
"We would hope that policymakers would be influenced by the success of the program and by its inherent simplicity," said the lead physician. "We hope that they would look to this as a useful model of prevention that they could employ in their own setting or perhaps in primary-care centers where there is a multidisciplinary team available."
The 12- to 16-week primary-prevention program including patients and partners or spouses, was designed to alter the lifestyle behaviors of spouses/partners because aberrant behavior, especially in terms of diet and physical-activity patterns, tends to be shared.
Overall, mean body-mass index and waist-circumference measurements were reduced in the high-risk patients and their partners. In addition, there was greater adherence to the Mediterranean diet; a larger proportion of individuals reaching the daily recommended targets of fruit, vegetable, and fish consumption; and a reduction in salt use. There were dramatic improvements in physical-activity levels, with more than 60% of patients and their partners meeting the daily requirement for physical activity, up from 11% of patients and 20% of partners who were exercising before the intervention.
Sustainable and simple, "this is a model of a primary-prevention practice that we would hope would be disseminated throughout Ireland," said the lead physician.
Steve: Sustainable and simple. Words to live by.
Friday, May 4, 2012
Foods That Provide Hidden Vit D Treasure
Would it surprise you to know that meat, fish, and eggs not only provide vitamin D, but a major metabolite of vitamin D3 that is absorbed five times as well as supplemental D3?
Researchers in the June issue of American Journal of Clinical Nutrition explored the relative potency of the metabolite, 25-hydroxyvitamin D3, to vitamin D3 so that food-composition tables can better reflect the true vitamin D nutritive value of certain foods.
The study was performed in healthy, free-living adults to investigate whether the intake of 25-hydroxyvitamin D3 is 5 times more potent in raising serum 25-hydroxyvitamin D [25(OH)D] during winter compared with an equivalent amount of vitamin D3. A randomized, placebo-controlled, double-blind intervention study was conducted in adults aged 50 years who consumed a placebo, vitamin D3, or equivalent 25-hydroxyvitamin D3 daily throughout 10 weeks of winter. Serum 25(OH)D was measured.
They found that each microgram of orally consumed 25-hydroxyvitamin D3 (the metabolite) was about 5 times more effective in raising serum 25(OH)D in older adults in winter than an equivalent amount of vitamin D3.
30%, 12–14%, and 9% of the median daily intake of vitamin D in 18–64-y-olds comes from meat and meat products, fish and fish products, and egg and egg-dish food groupings, respectively in Ireland. Likewise, these 3 food groupings collectively make a significant contribution (55.5%) to the MDI of vitamin D in adults in the United Kingdom. In the US, adolescent girls in the National Heart, Lung and Blood Institute Growth and Health Study, the meat and bean food group contributed 4% and 26% to the MDI of vitamin D in white and African American girls, respectively.
30%, 12–14%, and 9% of the median daily intake of vitamin D in 18–64-y-olds comes from meat and meat products, fish and fish products, and egg and egg-dish food groupings, respectively in Ireland. Likewise, these 3 food groupings collectively make a significant contribution (55.5%) to the MDI of vitamin D in adults in the United Kingdom. In the US, adolescent girls in the National Heart, Lung and Blood Institute Growth and Health Study, the meat and bean food group contributed 4% and 26% to the MDI of vitamin D in white and African American girls, respectively.
Osteoporosis Update
Alcohol
Moderate alcohol consumption has been shown to be positively associated with increased bone mineral density (BMD). However, other lifestyle choices have also been shown to have an effect on bone health. An American Journal of Clinical Nutrition study examined the association between alcohol intake and Bone Mineral Density in 3218 women around menopause and to determine whether any association is independent of other lifestyle choices. Women who consumed one drink per day of alcohol had a significantly greater femoral neck and lumbar spine Bone Mineral Density than did those who never consumed alcohol.
Healing Bone Injuries
A human-made package filled with nature's bone-building ingredients heals serious bone injuries faster than products currently available. Tested on sheep, the surgical elastic "implant device," essentially a wrapping that mimics bone's own sock-like sheath called periosteum, delivered stem cells, growth factors and other natural components of the periosteum to heal a defect that would not heal on its own if left untreated, as reported in journal PLoS One.
Scientists filled the pockets of one set of the devices with membranes made of collagen, which is a natural component of the periosteum; a second set was filled with collagen membranes seeded with cells that reside in the periosteum , and a third set with strips of periosteum. Both the collagen seeded sheets and the periosteum strips showed the most promising results.
Beyond bone, the device is flexible enough to be used in a broad array of applications including growing cartilage for orthopedics, to fuse vertebrae, as a delivery system for stem cells, antibiotics, transcription factors and more.
Diet Patterns
According to a study in British Journal of Nutrition, studies of individual nutrients or foods have revealed much about dietary influences on bone, but not in young adults. Researchers examined the relationship between dietary patterns, and bone mineral status, the collective term for bone mineral content (BMC) and bone mineral density (BMD) in young adults (20–25 years). Women in the top compared to the bottom fifth of the ‘Nuts and Meat’ pattern had greater femoral neck BMD and BMC. Men in the top compared to the bottom fifth of the ‘Refined Carbohydrate’ pattern had lower femoral BMC. In conclusion, adherence to a ‘Nuts and Meat’ dietary pattern may be associated with greater BMS in young women and a ‘Refined’ dietary pattern may be detrimental for bone health in young men.
Supplements
Osteoporosis International published a recent study stating that "lifetime supplementation with vitamin K, vitamin D3, and calcium is likely to reduce bone fractures and increase survival in postmenopausal women. It would be a cost-effective intervention at commonly used thresholds, but further research on the effect of vitamin K on fractures is warranted. Compared to no supplementation, vitamin D(3) (800 IU/day) with calcium (1,200 mg/day), and vitamin K(2) (45 mg/day) with vitamin D(3) and calcium (at the same doses) were examined.
Adding vitamin K(2) to vitamin D(3) with calcium reduced the lifetime probability of at least one fracture by 25%, increased discounted survival by 0.7 quality-adjusted life-years and discounted costs by $8,956 per person. Lifetime supplementation with vitamin K, vitamin D(3), and calcium is likely to reduce fractures and increase survival in postmenopausal women. Given high uncertainty around the cost-effectiveness estimates, further research on the efficacy of vitamin K on fractures is warranted.
Bonnie: we have seen more and more positive data on vitamin K for bone fracture prevention. While it is much easier to attain from diet (especially with ideal vegetable consumption) than vitamin D, we are getting closer to including it as a required supplemental nutrient, but are not there just yet.
Safety (or Lack Thereof) of Current Osteoporosis Drug Therapy
This was taken verbatim from the Agency for Healthcare Research and Quality latest report on the challenges of treating osteoporosis.
Steve: this also is a direct quote from the report: "Dietary and supplemental calcium and vitamin D, as well as weight bearing exercise, play important roles in preserving bone mass. Lifelong calcium intake is required for the acquisition of peak bone mass and for the subsequent maintenance of bone health. When serum calcium levels are inadequate, bone tissue is resorbed from the skeleton to maintain serum calcium at a constant level. Adequate vitamin D levels play a key role in calcium absorption, bone health, muscle performance, balance, and fall prevention."
Moderate alcohol consumption has been shown to be positively associated with increased bone mineral density (BMD). However, other lifestyle choices have also been shown to have an effect on bone health. An American Journal of Clinical Nutrition study examined the association between alcohol intake and Bone Mineral Density in 3218 women around menopause and to determine whether any association is independent of other lifestyle choices. Women who consumed one drink per day of alcohol had a significantly greater femoral neck and lumbar spine Bone Mineral Density than did those who never consumed alcohol.
Healing Bone Injuries
A human-made package filled with nature's bone-building ingredients heals serious bone injuries faster than products currently available. Tested on sheep, the surgical elastic "implant device," essentially a wrapping that mimics bone's own sock-like sheath called periosteum, delivered stem cells, growth factors and other natural components of the periosteum to heal a defect that would not heal on its own if left untreated, as reported in journal PLoS One.
Scientists filled the pockets of one set of the devices with membranes made of collagen, which is a natural component of the periosteum; a second set was filled with collagen membranes seeded with cells that reside in the periosteum , and a third set with strips of periosteum. Both the collagen seeded sheets and the periosteum strips showed the most promising results.
Beyond bone, the device is flexible enough to be used in a broad array of applications including growing cartilage for orthopedics, to fuse vertebrae, as a delivery system for stem cells, antibiotics, transcription factors and more.
Diet Patterns
According to a study in British Journal of Nutrition, studies of individual nutrients or foods have revealed much about dietary influences on bone, but not in young adults. Researchers examined the relationship between dietary patterns, and bone mineral status, the collective term for bone mineral content (BMC) and bone mineral density (BMD) in young adults (20–25 years). Women in the top compared to the bottom fifth of the ‘Nuts and Meat’ pattern had greater femoral neck BMD and BMC. Men in the top compared to the bottom fifth of the ‘Refined Carbohydrate’ pattern had lower femoral BMC. In conclusion, adherence to a ‘Nuts and Meat’ dietary pattern may be associated with greater BMS in young women and a ‘Refined’ dietary pattern may be detrimental for bone health in young men.
Supplements
Osteoporosis International published a recent study stating that "lifetime supplementation with vitamin K, vitamin D3, and calcium is likely to reduce bone fractures and increase survival in postmenopausal women. It would be a cost-effective intervention at commonly used thresholds, but further research on the effect of vitamin K on fractures is warranted. Compared to no supplementation, vitamin D(3) (800 IU/day) with calcium (1,200 mg/day), and vitamin K(2) (45 mg/day) with vitamin D(3) and calcium (at the same doses) were examined.
Adding vitamin K(2) to vitamin D(3) with calcium reduced the lifetime probability of at least one fracture by 25%, increased discounted survival by 0.7 quality-adjusted life-years and discounted costs by $8,956 per person. Lifetime supplementation with vitamin K, vitamin D(3), and calcium is likely to reduce fractures and increase survival in postmenopausal women. Given high uncertainty around the cost-effectiveness estimates, further research on the efficacy of vitamin K on fractures is warranted.
Bonnie: we have seen more and more positive data on vitamin K for bone fracture prevention. While it is much easier to attain from diet (especially with ideal vegetable consumption) than vitamin D, we are getting closer to including it as a required supplemental nutrient, but are not there just yet.
Safety (or Lack Thereof) of Current Osteoporosis Drug Therapy
This was taken verbatim from the Agency for Healthcare Research and Quality latest report on the challenges of treating osteoporosis.
| What are the short- and long-term harms (adverse effects) of the above therapies? | |
|---|---|
| High | Participants who took raloxifene showed higher odds for pulmonary embolism than did participants who took a placebo. Raloxifene participants also had greater odds of thromboembolic events. |
| High | Estrogen and estrogen-progestin combination participants had higher odds of cerebrovascular accident (CVA) and thromboembolic events than did placebo participants. |
| High | A pooled analysis of ten trials found an increased risk with raloxifene for myalgias, cramps, and limb pain. |
| High | We categorized conditions such as acid reflux, esophageal irritation, nausea, vomiting, and heartburn as “mild upper GI events.” Our pooled analyses showed alendronate had a slightly increased risk of mild upper GI events. Alendronate participants also had higher odds of mild upper GI events in head-to-head trials vs. menopausal hormone therapy. Pooled analysis also showed alendronate users to be at an increased risk for mild GI events compared to denosumab. Denosumab was also associated with an increase in mild GI events. |
| Low | A new systematic review of 15 placebo-controlled trials of calcium (administered for bone health in all trials but one) identified a statistically significant increase in the risk of myocardial infarction; however serious concerns have been expressed about possible bias. |
| Moderate | Teriparatide-treated participants showed a significant increase in hypercalcemia. |
| Insufficient | The literature is equivocal on the potential association between bisphosphonates and the risk of atrial fibrillation. |
| High | One trial, one post hoc analysis of three trials, two large observational studies, and a review of 2,408 cases of osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis prevention or treatment found that the incidence of osteonecrosis of the jaw in this group was small, ranging from less than one to 28 cases per 100,000 person-years of treatment. |
| High | Our pooled analysis of eight trials found an increased risk with raloxifene of hot flashes. |
| Limited data from clinical trials and observational studies support a possible association between bisphosphonate use and atypical subtrochanteric fractures of the femur. Data are not consistent, nevertheless these data were sufficient for FDA to issue a Warning regarding this possible adverse event. | |
| Moderate | A pooled analysis of three trials of teriparatide found an increased risk of headaches. |
| High | A pooled analysis of four trials of denosumab found an increased risk of rash but no increase in the risk for injection-site reactions. |
| Moderate | A small number of clinical trials have reported an increased risk of hypocalcemia in patients treated with alendronate and zoledronic acid. |
| Insufficient | Four observational studies that assessed whether the use of an oral bisphosphonate is associated with an increased risk of esophageal cancer had mixed findings. |
| High | A pooled analysis of four trials of denosumab found an increased risk for infection. |
Steve: this also is a direct quote from the report: "Dietary and supplemental calcium and vitamin D, as well as weight bearing exercise, play important roles in preserving bone mass. Lifelong calcium intake is required for the acquisition of peak bone mass and for the subsequent maintenance of bone health. When serum calcium levels are inadequate, bone tissue is resorbed from the skeleton to maintain serum calcium at a constant level. Adequate vitamin D levels play a key role in calcium absorption, bone health, muscle performance, balance, and fall prevention."
Friday, April 27, 2012
Vitamin D Update
According to an editorial in Current Opinion in Allergy and Clinical Immunology, allergists must consider the possibility that abnormal vitamin D blood levels – or even the local tissue concentration of vitamin D – could be a critical influencing factor in chronic rhinitis and asthma onset.
Alzheimer's
In women with the average age of 80, the highest average intakes of vitamin D were associated with a 77% decrease in the risk of Alzheimer’s, according to a study in the The Journal of Gerontology: Medical Science.
Researchers have identified the key genes and celullar signalling networks regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease. Published in the Journal of Alzheimer's Disease, the early findings show this is done by stimulating the immune system.
Back Surgery
Before considering spine-related surgery, you may want to check your vitamin D level first. Spine-related disability is higher in patients with low levels of vitamin D. A study presented at the North American Spine Society found that 65% of patients undergoing spinal fusion had vitamin D inadequacy ( below 32), which can delay recovery.
Bone Fractures
New research presented at the 2012 Annual Meeting of the American Academy of Orthopedic Surgeons found that 77 percent of orthopedic trauma patients had deficient or insufficient levels of vitamin D. Participants with vitamin D levels below 20 were categorized as "deficient," those with levels between 20 and 32 "insufficient," and levels between 40 and 70 considered "healthy".
Another study presented at the meeting stated that 44% of postmenopausal women treated for a distal radius fracture (DRF) were either vitamin D deficient or insufficient.
Cholesterol
Researchers in British Journal of Nutrition investigated evidence indicating that vitamin D deficiency contributes to abnormal lipid markers in women. Vitamin D3 supplementation in healthy premenopausal overweight and obese women were randomly allocated to receive vitamin D or placebo for 12 weeks. In addition to the significant decrease of body fat mass, the vitamin D3 group showed significantly improved HDL-cholesterol, apoA-I concentrations and LDL-cholesterol:apoB-100 ratio.
Cancer
Researchers investigated the association between serum levels of 25-hydroxyvitamin D and risk of death in Norwegian cancer patients. The study population was 658 patients with cancers of the breast (n = 251), colon (n = 52), lung (n = 210), and lymphoma (n = 145). 343 (86%) died from cancer. Patients with 25-OHD levels below 46 at diagnosis experienced shorter survival. In the Cancer, Causes, and Control study, compared to patients with the lowest of serum 25-OHD, the risk of cancer death among patients in the highest quartile was significantly reduced.
Authors of an American Journal of Epidemiology study measured plasma 25-hydroxyvitamin D in healthy volunteer who underwent total colonoscopy, and evaluated its influence on colorectal adenoma. Compared with the lowest levels of plasma 25-hydroxyvitamin D, only the highest was related to a significantly decreased odds ratio of colorectal adenoma.
Vitamin D supplements are necessary to avoid melanoma cases in temperate (colder) climates, according to a study in Cancer Causes Control. Out of 960 melanoma cases, most vitamin D levels were sub-optimal, especially in sun-sensitive individuals. Even in those with sun exposure, levels were better, but most were not considered optimal. Without supplementation, none of the cases had vitamin D levels that were considered optimal.
A Breast Cancer Research study including 1,295 incident postmenopausal breast cancer patients aged 50–74 years, found that lower serum 25(OH)D concentrations were associated with poorer overall survival and distant disease-free survival in postmenopausal breast cancer patients.
Diabetes
A higher-than-expected co-occurrence of low vitamin D levels and hyperglycemia (HbA1c more than 6.5%) are important public health concerns for older populations living in northern latitudes because both are common, and both have substantial adverse health consequences. According to the Journal of American Geriatric Society study, ensuring adequate vitamin D levels may help reverse the increasing trend in the development of diabetes mellitus and related complications in older people.
Fertility
There is evidence that vitamin D modulates reproductive processes in women and men. A European Journal of Endocrinology study found that the vitamin D receptor (VDR) and vitamin D metabolizing enzymes are found in reproductive tissues of women and men.
Researchers found that vitamin D is involved in female reproduction including in-vitro fertilization (IVF) outcome and polycystic ovary syndrome (PCOS). In PCOS women, low 25(OH)D levels are associated with obesity, metabolic and endocrine disturbances and vitamin D supplementation might improve menstrual frequency and metabolic disturbances in those women. Moreover, vitamin D might influence steroidogenesis of sex hormones (estradiol and progesterone) in healthy women.
In men, vitamin D is positively associated with semen quality and androgen status. Moreover, vitamin D treatment might increase testosterone levels.
Heart Failure
Researchers in European Journal of Heart Failure discovered that vitamin D deficiency is highly prevalent in Heart Failure patients and is a significant predictor of reduced survival. They found that vitamin D supplementation was associated with improved outcome.
Inflammation
Researchers have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In Journal of Immunology, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling. This study is the first to outline a clear chain of cellular events, from the binding of DNA, through a specific signaling pathway, to the reduction of proteins known to trigger inflammation.
Inflammatory Bowel Disease
In children and adolescents with inflammatory bowel disease (IBD) and insufficient serum vitamin D levels, taking 2,000 IU of vitamin D3 every day for six weeks, or a 50,000-IU dose of vitamin D2 every week, were both more effective at raising serum 25OHD concentration than 2,000 IU/day of vitamin D2. Vitamin D insufficiency is common in children with IBD said in a report in the Journal of Clinical Endocrinology and Metabolism.
Leprosy
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses. In one of the first laboratory studies of its kind, the leprosy pathogen Mycobacterium leprae was able to reduce and evade immune activity that is dependent on vitamin D. Researchers believe that a combination of vitamin D supplementation with a genetically targeted therapy may provide an optimal treatment approach to leprosy.
Menstrual Cramps
Women with a history of severe menstrual cramps reported significantly less pain when they took an ultra-high dose of vitamin D (300,000IU) five days before their next expected period, an Archives of Internal Medicine report explained. While no side effects were seen, researchers point out that the vitamin D dose used in the study, even when averaged over two months, was still higher than the "tolerable upper limit" and only should be considered under the supervision of a physician.
Metabolic Syndrome
Researchers in the Journal of Clinical Endocrinology and Metabolism found that those with lower vitamin D levels were more likely to be obese and have higher degrees of insulin resistance, when the hormone becomes less effective at lowering blood sugar. Hence, the study suggests that low vitamin D levels may play a role in the development of Type 2 diabetes as well.
Multiple Sclerosis
According to a study in Archives of Neurology, low serum vitamin D levels contribute to recurrent inflammatory spinal cord disease. Vitamin D is believed to play a role in preventing monophasic immune-mediated central nervous system attacks from developing into recurrent disease, but studies are scant. Researchers found that vitamin D levels are significantly lower in patients who developed recurrent spinal cord disease. This study now provides a basis for a trial of measuring 25-hydroxyvitamin D levels in these patient populations and assessing the influence of vitamin D supplementation on the frequency of relapses in those with recurrent inflammatory spinal cord disease.
Non-Hodgkin's Lymphoma
According to a study in Cancer Causes and Control, Non-Hodgkins is tied to vitamin D deficiency. Studies of risk of non-Hodgkin’s lymphoma have found both direct and inverse correlations with respect to solar ultraviolet (UV) doses. Reduced risk is generally found in midlatitudes, while increased risk is generally found at higher latitudes. It is suggested that reduced risk arises from vitamin D production from UVB irradiance, while increased risk arises from immunosuppression associated with UVA irradiance. The ratio of UVA to UVB increases with increasing latitude..
Pain
The aim of a British Journal of Nutrition study was to investigate associations between serum 25-hydroxy vitamin D and self-reported current symptoms of pain in 2070 adults aged 65 years and older. Results show that the symptoms of moderate/extreme pain were associated with poor vitamin D status.
Pregnancy
Results of a large study in Pediatrics suggest that maternal vitamin D status during pregnancy has an effect on the neurocognitive development of offspring. Pregnant women with insufficient serum 25-hydroxyvitamin D levels (below 46) had about a 2-fold higher risk of having a child with clinically significant language difficulties compared with pregnant women whose vitamin D levels were greater than 70.
Stress Fractures
A study of 6712 girls aged 9 to 15 years in Archives of Pediatric Adolescent Medicine to estimate the association between vitamin D intake and stress fracture risk among girls participating in at least 1 h/d of high-impact activity, among whom 90.0% of the stress fractures occurred, found that higher vitamin D intake predicted significantly lower risk of stress fracture.
Sun Exposure
Light-skinned people who avoid the sun are twice as likely to suffer from vitamin D deficiency as those who do not, according to a study of nearly 6,000 people in Cancer, Causes, and Control. The study adds to a growing debate about how to balance the dangers of sun exposure with the need for appropriate levels of vitamin D.
According to a study in Environmental Health Perspectives, most American children may not be going outside enough to meet their minimal (600 IU/day) or optimal (more than 1,200 IU/day) vitamin D requirements.
Where You Live Matters
When it comes to risks for vitamin D deficiency, and the medical care and costs associated with that deficiency, where you live appears to play an important role, according to the Journal of Rural Health. Of 9396 veterans treated from 2003 to 2009, the highest levels were observed for urban residents (29.5 ng/mL), followed by rural residents (28.0 ng/mL), and the lowest for large metro residents (27.5 ng/mL).
Tuesday, April 24, 2012
Med Alert
16 Drugs on the FDA Watch List
http://www.medscape.com/viewarticle/762205
Acne Medication
Use of isotretinoin (Roaccutane, formerly known as Accutane) to treat severe acne was linked to a two-fold risk of developing eye problems, such as pink eye, styes and dryness. Isotretinoin is known to have serious side effects, such as bone growth delays in teenagers and miscarriages and birth defects when taken by pregnant women.
The new Archives of Dermatology study found that of nearly 15,000 Israeli adolescents and young adults, 14% of those taking isotretinoin were treated for eye conditions within a year of starting the drug, compared to 7% of an acne-free comparison group.
Blood Pressure Medication
Aliskiren-containing medications are renin inhibitors used to treat high blood pressure (hypertension). They go by the names:
Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide)
Tekturna (aliskiren hemifumarate)
Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide)
Tekamlo (aliskiren hemifumarate and amlodipine besylate)
Valturna (aliskiren hemifumarate and valsartan).
FDA notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment. These drug combinations should not be used (are contraindicated) in patients with diabetes. In addition, avoid use of aliskiren with ARBs or ACEIs in patients with moderate to severe renal impairment.
Bone Loss Medication
Patients taking oral bisphosphonates for the first time may be at higher risk of developing scleritis and uveitis (eye diseases), according to an April 2 study in Canadian Medical Association Journal.
The incidence rate among 10,827 first-time bisphosphonate users was 29/10,000 person-years for uveitis and 63/10,000 person-years for scleritis. In contrast, the incidence rate among 923,320 nonusers was 20/10,000 person-years for uveitis and 36/10,000 for scleritis.
"This is the first study that quantifies the risk of uveitis and scleritis with these drugs. In the past, much attention has been given to other adverse events related to these drugs, mainly linking them to increasing the risk of atypical fractures, atrial fibrillation, and gastrointestinal cancer," the lead author said.
It is possible that the release of inflammatory mediators triggered by the use of bisphosphonates may be the mechanism behind the development of scleritis and uveitis among first-time users. Left untreated, uveitis can lead to cataracts, glaucoma, macular edema, and scleral perforation.
Hair Loss Medication
Two Merck & Co. drugs, one to treat hair loss in men (Propecia), the other to treat an enlarged prostate gland (Proscar), will get revised labels warning of potential sexual side effects that can last even after patients stop taking the drugs. Both drugs share the same chemical compound, called finasteride.
The new Propecia label will include a warning of "libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug," the FDA said in a recent news release.The Proscar label will include a warning about "decreased libido that continued after discontinuation of the drug," the agency said. The labels of both drugs will also carry about a description of reports of male infertility and/or poor semen quality that clears up or improves after the drugs are stopped.
Statins
Statins were responsible for rhabdomyolysis (muscle breakdown) in 7.5% of patients diagnosed with the skeletal muscle condition, according to a review of International Classification of Disease, Ninth Edition (ICD-9) codes. Publishing their findings as a letter to the editor in the Journal of the American Medical Association, reseacrhers also confirmed a significantly higher risk of rhabdomyolysis in patients treated with high doses of simvastatin.
In a separate warning from the FDA, taking Statins With HIV or Hepatitis C Drugs raises muscle injury risk
Weight-Loss Medication
Orlistat is an inhibitor of gastric and pancreatic lipase with proven efficacy in the augmentation and maintenance of weight loss. Although its use has been limited by troublesome but benign gastrointestinal side effects, it has more recently been associated with acute kidney injury (AKI). In a Therapeutic Advances in Drug Research review, although the author's cannot yet draw an unequivocal causal link between orlistat and AKI, there is enough evidence to include orlistat exposure in the clinical assessment of patients with AKI.
MedWatch's Most Recent Safety Page
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm300978.htm?source=govdelivery
http://www.medscape.com/viewarticle/762205
Acne Medication
Use of isotretinoin (Roaccutane, formerly known as Accutane) to treat severe acne was linked to a two-fold risk of developing eye problems, such as pink eye, styes and dryness. Isotretinoin is known to have serious side effects, such as bone growth delays in teenagers and miscarriages and birth defects when taken by pregnant women.
The new Archives of Dermatology study found that of nearly 15,000 Israeli adolescents and young adults, 14% of those taking isotretinoin were treated for eye conditions within a year of starting the drug, compared to 7% of an acne-free comparison group.
Blood Pressure Medication
Aliskiren-containing medications are renin inhibitors used to treat high blood pressure (hypertension). They go by the names:
Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide)
Tekturna (aliskiren hemifumarate)
Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide)
Tekamlo (aliskiren hemifumarate and amlodipine besylate)
Valturna (aliskiren hemifumarate and valsartan).
FDA notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment. These drug combinations should not be used (are contraindicated) in patients with diabetes. In addition, avoid use of aliskiren with ARBs or ACEIs in patients with moderate to severe renal impairment.
Bone Loss Medication
Patients taking oral bisphosphonates for the first time may be at higher risk of developing scleritis and uveitis (eye diseases), according to an April 2 study in Canadian Medical Association Journal.
The incidence rate among 10,827 first-time bisphosphonate users was 29/10,000 person-years for uveitis and 63/10,000 person-years for scleritis. In contrast, the incidence rate among 923,320 nonusers was 20/10,000 person-years for uveitis and 36/10,000 for scleritis.
"This is the first study that quantifies the risk of uveitis and scleritis with these drugs. In the past, much attention has been given to other adverse events related to these drugs, mainly linking them to increasing the risk of atypical fractures, atrial fibrillation, and gastrointestinal cancer," the lead author said.
It is possible that the release of inflammatory mediators triggered by the use of bisphosphonates may be the mechanism behind the development of scleritis and uveitis among first-time users. Left untreated, uveitis can lead to cataracts, glaucoma, macular edema, and scleral perforation.
Hair Loss Medication
Two Merck & Co. drugs, one to treat hair loss in men (Propecia), the other to treat an enlarged prostate gland (Proscar), will get revised labels warning of potential sexual side effects that can last even after patients stop taking the drugs. Both drugs share the same chemical compound, called finasteride.
The new Propecia label will include a warning of "libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug," the FDA said in a recent news release.The Proscar label will include a warning about "decreased libido that continued after discontinuation of the drug," the agency said. The labels of both drugs will also carry about a description of reports of male infertility and/or poor semen quality that clears up or improves after the drugs are stopped.
Statins
Statins were responsible for rhabdomyolysis (muscle breakdown) in 7.5% of patients diagnosed with the skeletal muscle condition, according to a review of International Classification of Disease, Ninth Edition (ICD-9) codes. Publishing their findings as a letter to the editor in the Journal of the American Medical Association, reseacrhers also confirmed a significantly higher risk of rhabdomyolysis in patients treated with high doses of simvastatin.
In a separate warning from the FDA, taking Statins With HIV or Hepatitis C Drugs raises muscle injury risk
Weight-Loss Medication
Orlistat is an inhibitor of gastric and pancreatic lipase with proven efficacy in the augmentation and maintenance of weight loss. Although its use has been limited by troublesome but benign gastrointestinal side effects, it has more recently been associated with acute kidney injury (AKI). In a Therapeutic Advances in Drug Research review, although the author's cannot yet draw an unequivocal causal link between orlistat and AKI, there is enough evidence to include orlistat exposure in the clinical assessment of patients with AKI.
MedWatch's Most Recent Safety Page
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm300978.htm?source=govdelivery
Friday, April 20, 2012
The future of disease screening
(continued)
Researchers have compiled a detailed molecular profile of an individual, with the goal of learning how to construct an integrative personal "omics" profile, how the profile changes in health and disease, and how to use this information to gauge risk and better understand disease states.
The report, published in Cell, analyzed molecular changes observed in health and disease, including the unexpected development of type 2 diabetes during the study. The group leader Michael Snyder, PhD, chair of the Department of Genetics, Stanford University School of Medicine, provided about 20 blood samples during the 14-month study for analyses, using peripheral blood mononuclear cells, plasma, and sera. Although the 14-month study has now been published, the sampling and analysis continue. "Realistically, other things may happen to me over the rest of my life, and we hope to capture those as well," Initial whole-genome sequencing (WGS) of Dr. Snyder's DNA was performed using several technologies, as was exome sequencing (the part of the genome coding for proteins and other gene products).
Overall, his blood samples were analyzed for nearly 40,000 variables, including profiles of 19,000 or more transcripts that carry the information from about 12,000 genes, levels of 4000 proteins, and 5000 metabolite peaks (only 1000 are known). The results revealed disease variants associated with emphysema, aplastic anemia, type 2 diabetes, and hypertriglyceridemia, among other diseases. The RiskOGram algorithm, which "integrates information from multiple alleles associated with disease risk," indicated an elevated risk for coronary artery disease, basal cell carcinoma, hypertriglyceridemia, and type 2 diabetes.
"Right now we're trying to collect as much information as we can, and we'd like to do this, obviously, with multiple individuals. It may be, at the end of the day, you don't need to make 40,000 measurements like we did on me," said Dr. Snyder. However, "for the average person, I still think it's going to be more than 20 like we do now.... We should be profiling hundreds, if not thousands, kind of routinely as part of an exam." More information is available that way, he said. Asked which analyses were most informative clinically, Dr. Snyder laughed. "I know this will sound like a cop-out, but for me, it was best to analyze everything."
The transcriptome found the most information, but if they had only looked at the transcriptome, they would have missed other equally relevant things, he said. "Some signatures showed up with just the proteomics, and some only showed up with all 3 profiles [transcriptome, proteome, metabolome].... There's really more information in all 3 than in any 1 of these alone," Dr. Snyder added. "We didn't know that for sure going in, but it was refreshing and somewhat reassuring to see this. It makes sense that you'll get a more complete picture when you follow everything."
One goal of the study was to compare molecular analyses in health and disease. Dr. Snyder developed 2 viral infections during the study: a rhinovirus infection on day 0, and a respiratory syncytial virus (RSV) infection starting on day 289. Twelve days later (day 301), his glucose levels became elevated. The elevation lasted several months until, based on glucose levels and HbA1c, his physician diagnosed type 2 diabetes on day 369. "People have associated diabetes with stress responses before, but to the best of my knowledge, not with viral infections. So this was a new angle," Dr. Snyder noted. "It could be that the virus acted like a stress inducer. Our interpretation of this is that my genome has me predisposed and that, in combination with the viral infection, maybe the stress-response part of the viral infection induced the disease." Asked why this infection induced diabetes when previous infections had not, Dr. Snyder said: "This RSV is a pretty nasty one. Another factor may be the case as well: I'm in my 50s and, to be honest, that's when things break down. It's quite likely that the combination of being in my 50s, with this viral stress and, again, my genome combination is what triggered it."
Diabetes should be regarded as "hundreds of diseases," noted Dr. Snyder. "Some people are insulin-resistant, some aren't; some respond to metformin, some don't; some seem to be associated with inflammation, some aren't. So I think diabetes probably is many diseases, all lumped together, because the 1 common characteristic is high glucose. I'm hopeful that by doing more of these sorts of studies, we can look at the molecular breakdown of how many types there are, and then be able to better stratify it and better treat it," Dr. Snyder said.
"I foresee that a longitudinal 'Omics' study as described in Snyder's landmark paper will indeed become common in the next 10 to 20 years," said Jan Korbel, PhD, group leader at the European Molecular Biology Laboratory, Heidelberg, Germany.
"A first promising application would be in families with particular hereditary risk factors, where whole-omics profiling could be used to monitor disease onset closely." George M. Church, PhD, professor of genetics at Harvard Medical School, Boston, Massachusetts, anticipates that work-ups of this type might become common for individuals in "maybe 4 years."
Eric J. Topol, MD, professor of translational genomics at the Scripps Research Institute, La Jolla, California, expects that such work-ups could "be common now for select individuals with a rare, disabling, even life-threatening condition.
Unlike the Snyder study of 20 serial blood draws...a single assessment is eminently doable and could shed considerable light on root cause and potential targeted therapy." "I think it's going to be the future of medicine," concluded Dr. Snyder. "I'd love to see medicine in the future be a case where you get a little prick in your finger, just like a diabetes test, and you measure 5000 things instead of 1 thing (just glucose) right now. I'd love to see it be a home test, where you can monitor your own health routinely," he said. "That's my vision for medicine in the future."
Researchers have compiled a detailed molecular profile of an individual, with the goal of learning how to construct an integrative personal "omics" profile, how the profile changes in health and disease, and how to use this information to gauge risk and better understand disease states.
The report, published in Cell, analyzed molecular changes observed in health and disease, including the unexpected development of type 2 diabetes during the study. The group leader Michael Snyder, PhD, chair of the Department of Genetics, Stanford University School of Medicine, provided about 20 blood samples during the 14-month study for analyses, using peripheral blood mononuclear cells, plasma, and sera. Although the 14-month study has now been published, the sampling and analysis continue. "Realistically, other things may happen to me over the rest of my life, and we hope to capture those as well," Initial whole-genome sequencing (WGS) of Dr. Snyder's DNA was performed using several technologies, as was exome sequencing (the part of the genome coding for proteins and other gene products).
Overall, his blood samples were analyzed for nearly 40,000 variables, including profiles of 19,000 or more transcripts that carry the information from about 12,000 genes, levels of 4000 proteins, and 5000 metabolite peaks (only 1000 are known). The results revealed disease variants associated with emphysema, aplastic anemia, type 2 diabetes, and hypertriglyceridemia, among other diseases. The RiskOGram algorithm, which "integrates information from multiple alleles associated with disease risk," indicated an elevated risk for coronary artery disease, basal cell carcinoma, hypertriglyceridemia, and type 2 diabetes.
"Right now we're trying to collect as much information as we can, and we'd like to do this, obviously, with multiple individuals. It may be, at the end of the day, you don't need to make 40,000 measurements like we did on me," said Dr. Snyder. However, "for the average person, I still think it's going to be more than 20 like we do now.... We should be profiling hundreds, if not thousands, kind of routinely as part of an exam." More information is available that way, he said. Asked which analyses were most informative clinically, Dr. Snyder laughed. "I know this will sound like a cop-out, but for me, it was best to analyze everything."
The transcriptome found the most information, but if they had only looked at the transcriptome, they would have missed other equally relevant things, he said. "Some signatures showed up with just the proteomics, and some only showed up with all 3 profiles [transcriptome, proteome, metabolome].... There's really more information in all 3 than in any 1 of these alone," Dr. Snyder added. "We didn't know that for sure going in, but it was refreshing and somewhat reassuring to see this. It makes sense that you'll get a more complete picture when you follow everything."
One goal of the study was to compare molecular analyses in health and disease. Dr. Snyder developed 2 viral infections during the study: a rhinovirus infection on day 0, and a respiratory syncytial virus (RSV) infection starting on day 289. Twelve days later (day 301), his glucose levels became elevated. The elevation lasted several months until, based on glucose levels and HbA1c, his physician diagnosed type 2 diabetes on day 369. "People have associated diabetes with stress responses before, but to the best of my knowledge, not with viral infections. So this was a new angle," Dr. Snyder noted. "It could be that the virus acted like a stress inducer. Our interpretation of this is that my genome has me predisposed and that, in combination with the viral infection, maybe the stress-response part of the viral infection induced the disease." Asked why this infection induced diabetes when previous infections had not, Dr. Snyder said: "This RSV is a pretty nasty one. Another factor may be the case as well: I'm in my 50s and, to be honest, that's when things break down. It's quite likely that the combination of being in my 50s, with this viral stress and, again, my genome combination is what triggered it."
Diabetes should be regarded as "hundreds of diseases," noted Dr. Snyder. "Some people are insulin-resistant, some aren't; some respond to metformin, some don't; some seem to be associated with inflammation, some aren't. So I think diabetes probably is many diseases, all lumped together, because the 1 common characteristic is high glucose. I'm hopeful that by doing more of these sorts of studies, we can look at the molecular breakdown of how many types there are, and then be able to better stratify it and better treat it," Dr. Snyder said.
"I foresee that a longitudinal 'Omics' study as described in Snyder's landmark paper will indeed become common in the next 10 to 20 years," said Jan Korbel, PhD, group leader at the European Molecular Biology Laboratory, Heidelberg, Germany.
"A first promising application would be in families with particular hereditary risk factors, where whole-omics profiling could be used to monitor disease onset closely." George M. Church, PhD, professor of genetics at Harvard Medical School, Boston, Massachusetts, anticipates that work-ups of this type might become common for individuals in "maybe 4 years."
Eric J. Topol, MD, professor of translational genomics at the Scripps Research Institute, La Jolla, California, expects that such work-ups could "be common now for select individuals with a rare, disabling, even life-threatening condition.
Unlike the Snyder study of 20 serial blood draws...a single assessment is eminently doable and could shed considerable light on root cause and potential targeted therapy." "I think it's going to be the future of medicine," concluded Dr. Snyder. "I'd love to see medicine in the future be a case where you get a little prick in your finger, just like a diabetes test, and you measure 5000 things instead of 1 thing (just glucose) right now. I'd love to see it be a home test, where you can monitor your own health routinely," he said. "That's my vision for medicine in the future."